Page last updated: 2024-08-22

2,2-bis(bromomethyl)-1,3-propanediol and Colonic Neoplasms

2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisetti, N; Bornet, F; Bouhnik, Y; FlouriƩ, B; Gailing, MF; Guibert, A; Rambaud, JC; Riottot, M1

Trials

1 trial(s) available for 2,2-bis(bromomethyl)-1,3-propanediol and Colonic Neoplasms

ArticleYear
Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans.
    Nutrition and cancer, 1996, Volume: 26, Issue:1

    Topics: Adult; beta-Fructofuranosidase; Bifidobacterium; Bile Acids and Salts; Colonic Neoplasms; Feces; Female; Fructose; Glucuronidase; Glycoside Hydrolases; Humans; Hydrogen-Ion Concentration; Male; NADH, NADPH Oxidoreductases; Nitroreductases; Oligosaccharides; Placebos; Sterols

1996